Literature DB >> 14973782

Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I.

Christian Kranz1, Jonas Denecke, Ludwig Lehle, Kristina Sohlbach, Stefanie Jeske, Friedhelm Meinhardt, Rainer Rossi, Sonja Gudowius, Thorsten Marquardt.   

Abstract

This study describes the discovery of a new inherited disorder of glycosylation named "CDG-Ik." CDG-Ik (congenital disorder of glycoslyation type Ik) is based on a defect of human mannosyltransferase I (MT-I [MIM 605907]), an enzyme necessary for the elongation of dolichol-linked chitobiose during N-glycan biosynthesis. Mutations in semiconserved regions in the corresponding gene, HMT-1 (yeast homologue, Alg1), in two patients caused drastically reduced enzyme activity, leading to a severe disease with death in early infancy. One patient had a homozygous point mutation (c.773C-->T, S258L), whereas the other patient was compound heterozygous for the mutations c.773C-->T and c.1025A-->C (E342P). Glycosylation and growth of Alg1-deficient PRY56 yeast cells, showing a temperature-sensitive phenotype, could be restored by the human wild-type allele, whereas only slight restoration was observed after transformation with the patients' alleles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14973782      PMCID: PMC1182267          DOI: 10.1086/382493

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  17 in total

1.  Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts.

Authors:  K Lühn; T Marquardt; E Harms; D Vestweber
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

2.  Correction of leukocyte adhesion deficiency type II with oral fucose.

Authors:  T Marquardt; K Lühn; G Srikrishna; H H Freeze; E Harms; D Vestweber
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

3.  A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.

Authors:  Christian Thiel; Markus Schwarz; Jianhe Peng; Michal Grzmil; Martin Hasilik; Thomas Braulke; Alfried Kohlschütter; Kurt von Figura; Ludwig Lehle; Christian Körner
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

4.  A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If).

Authors:  C Kranz; J Denecke; M A Lehrman; S Ray; P Kienz; G Kreissel; D Sagi; J Peter-Katalinic; H H Freeze; T Schmid; S Jackowski-Dohrmann; E Harms; T Marquardt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Overexpression of GDP-mannose pyrophosphorylase in Saccharomyces cerevisiae corrects defects in dolichol-linked saccharide formation and protein glycosylation.

Authors:  Anna Janik; Monika Sosnowska; Joanna Kruszewska; Hubert Krotkiewski; Ludwig Lehle; Grazyna Palamarczyk
Journal:  Biochim Biophys Acta       Date:  2003-04-07

6.  Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method.

Authors:  R Daniel Gietz; Robin A Woods
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

7.  Deficiency of dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl mannosyltransferase causes congenital disorder of glycosylation type Ig.

Authors:  Christian Thiel; Markus Schwarz; Martin Hasilik; Ulrike Grieben; Folker Hanefeld; Ludwig Lehle; Kurt von Figura; Christian Körner
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

8.  Temperature-sensitive yeast mutants deficient in asparagine-linked glycosylation.

Authors:  T C Huffaker; P W Robbins
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

9.  Solubilization and characterization of the initial enzymes of the dolichol pathway from yeast.

Authors:  C B Sharma; L Lehle; W Tanner
Journal:  Eur J Biochem       Date:  1982-08

10.  N-glycosylation by transfer of GlcNAc2 from dolichol-PP-GlcNAc2 to the protein moiety of the major yeast exoglucanase.

Authors:  R Cueva; C Cotano; G Larriba
Journal:  Yeast       Date:  1998-06-15       Impact factor: 3.239

View more
  29 in total

1.  TMEM165 Deficiency: Postnatal Changes in Glycosylation.

Authors:  S Schulte Althoff; M Grüneberg; J Reunert; J H Park; S Rust; C Mühlhausen; Y Wada; R Santer; T Marquardt
Journal:  JIMD Rep       Date:  2015-08-04

2.  Congenital nephrotic syndrome with dysmorphic features and death in early infancy: Answers.

Authors:  Julien Heinrich Park; Martin Weissensteiner; Oliver Wagner; Yoshinao Wada; Stephan Rust; Janine Reunert; Thorsten Marquardt
Journal:  Pediatr Nephrol       Date:  2015-05-09       Impact factor: 3.714

3.  Clinical utility gene card for: ALG1 defective congenital disorder of glycosylation.

Authors:  Jaak Jaeken; Dirk Lefeber; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2015-02-04       Impact factor: 4.246

4.  Pseudogenes as an alternative source of natural antisense transcripts.

Authors:  Enrique M Muro; Miguel A Andrade-Navarro
Journal:  BMC Evol Biol       Date:  2010-11-03       Impact factor: 3.260

5.  Two Argentinean Siblings with CDG-Ix: A Novel Type of Congenital Disorder of Glycosylation?

Authors:  M B Bistué Millón; M A Delgado; N B Azar; N Guelbert; L Sturiale; D Garozzo; G Matthijs; J Jaeken; Raquel Dodelson de Kremer; C G Asteggiano
Journal:  JIMD Rep       Date:  2011-06-22

6.  Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype.

Authors:  S Huybrechts; C De Laet; P Bontems; S Rooze; H Souayah; Y Sznajer; L Sturiale; D Garozzo; G Matthijs; A Ferster; J Jaeken; P Goyens
Journal:  JIMD Rep       Date:  2011-11-02

7.  Congenital nephrotic syndrome in an infant with ALG1-congenital disorder of glycosylation.

Authors:  Lyndsay A Harshman; Bobby G Ng; Hudson H Freeze; Pamela Trapane; Anna Dolezal; Patrick D Brophy; Jane E Brumbaugh
Journal:  Pediatr Int       Date:  2016-06-21       Impact factor: 1.524

8.  Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.

Authors:  Christian G Frank; Claudia E Grubenmann; Wafaa Eyaid; Eric G Berger; Markus Aebi; Thierry Hennet
Journal:  Am J Hum Genet       Date:  2004-05-17       Impact factor: 11.025

9.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09

10.  Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG.

Authors:  Per Bengtson; Bobby G Ng; Jaak Jaeken; Gert Matthijs; Hudson H Freeze; Erik A Eklund
Journal:  J Inherit Metab Dis       Date:  2015-09-03       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.